Literature DB >> 30537064

Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma.

L Nájera1, M Alonso-Juarranz2, M Garrido3, C Ballestín2, L Moya4, M Martínez-Díaz5, R Carrillo4, A Juarranz6,7, F Rojo2, J M Cuezva3,5,8, J L Rodríguez-Peralto3,9.   

Abstract

BACKGROUND: Reprogramming of energy metabolism to enhanced aerobic glycolysis has been defined as a hallmark of cancer.
OBJECTIVES: To investigate the role of the mitochondrial proteins, β-subunit of the H+ -ATP synthase (β-F1-ATPase), and heat-shock protein 60 (HSP60), and the glycolytic markers, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and pyruvate kinase M2 (PKM2), as well as the bioenergetic cellular (BEC) index, in melanoma progression.
MATERIALS AND METHODS: The expression of energy metabolism proteins was assessed on a set of different melanoma cells representing the natural biological history of the disease: primary cultures of melanocytes, radial (WM35) and vertical (WM278) growth phases, and poorly (C81-61-PA) and highly (C8161-HA) aggressive melanoma cells. Cohorts of 63 melanocytic naevi, 55 primary melanomas and 35 metastases were used; and 113 primary melanoma and 33 metastases were used for validation.
RESULTS: The BEC index was significantly reduced in melanoma cells and correlated with their aggressive characteristics. Overexpression of HSP60, GAPDH and PKM2 was detected in melanoma human samples compared with naevi, showing a gradient of increased expression from radial growth phase to metastatic melanoma. The BEC index was also significantly reduced in melanoma samples and correlated with worse overall and disease-free survival; the multivariate Cox analysis showed that the BEC index (hazard ratio 0·64; 95% confidence interval 0·4-1·2) is an independent predictor for overall survival.
CONCLUSIONS: A profound alteration in the mitochondrial and glycolytic proteins and in the BEC index occurs in the progression of melanoma, which correlates with worse outcome, supporting that the alteration of the metabolic phenotype is crucial in melanoma transformation.
© 2018 British Association of Dermatologists.

Entities:  

Year:  2019        PMID: 30537064     DOI: 10.1111/bjd.17513

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Cancer Glycolytic Dependence as a New Target of Olive Leaf Extract.

Authors:  Jessica Ruzzolini; Silvia Peppicelli; Francesca Bianchini; Elena Andreucci; Silvia Urciuoli; Annalisa Romani; Katia Tortora; Giovanna Caderni; Chiara Nediani; Lido Calorini
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

2.  Discovery of Functional Alternatively Spliced PKM Transcripts in Human Cancers.

Authors:  Xiangyu Li; Woonghee Kim; Muhammad Arif; Chunxia Gao; Andreas Hober; David Kotol; Linnéa Strandberg; Björn Forsström; Åsa Sivertsson; Per Oksvold; Hasan Turkez; Morten Grøtli; Yusuke Sato; Haruki Kume; Seishi Ogawa; Jan Boren; Jens Nielsen; Mathias Uhlen; Cheng Zhang; Adil Mardinoglu
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

3.  m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning.

Authors:  Maoxin Huang; Yi Zhang; Xiaohong Ou; Caiyun Wang; Xueqing Wang; Bibo Qin; Qiong Zhang; Jie Yu; Jianxiang Zhang; Jianbin Yu
Journal:  J Oncol       Date:  2021-08-04       Impact factor: 4.375

4.  Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy.

Authors:  Laura Torresano; Fulvio Santacatterina; Sonia Domínguez-Zorita; Cristina Nuevo-Tapioles; Alfonso Núñez-Salgado; Pau B Esparza-Moltó; Lucía González-Llorente; Inés Romero-Carramiñana; Cristina Núñez de Arenas; Brenda Sánchez-Garrido; Laura Nájera; Clara Salas; Mariano Provencio; José M Cuezva
Journal:  Oncogenesis       Date:  2022-05-09       Impact factor: 6.524

5.  Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy.

Authors:  Marta Mascaraque-Checa; María Gallego-Rentero; Jimena Nicolás-Morala; Mikel Portillo-Esnaola; José M Cuezva; Salvador González; Yolanda Gilaberte; Ángeles Juarranz
Journal:  Mol Metab       Date:  2022-04-09       Impact factor: 8.568

6.  WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis.

Authors:  Ren-Shu Zhang; Zhi-Ke Li; Jie Liu; Yao-Tiao Deng; Yu Jiang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

Review 7.  Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.

Authors:  Anna Han; Zachary T Schug; Andrew E Aplin
Journal:  Trends Cancer       Date:  2021-06-11

8.  High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma.

Authors:  Long Long; Mengxi Chen; Yu Yuan; Alex Lau Ming; Wei Guo; Kaisong Wu; Honglei Chen
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.